The long-term stability of amorphous silicon flat panel imaging devices for dosimetry purposes.

This study was carried out to determine the stability of the response of amorphous silicon (a-Si)-flat panel imagers for dosimetry applications. Measurements of the imager's response under reference conditions were performed on a regular basis for four detectors of the same manufacturer. We found that the ambient temperature influenced the dark-field, while the gain of the imager signal was unaffected. Therefore, temperature fluctuations were corrected for by applying a "dynamic" darkfield correction. This correction method also removed the influence of a small, irreversible increase of the dark-field current, which was equal to 0.5% of the dynamic range of the imager per year and was probably caused by mild radiation damage to the a-Si array. By applying a dynamic dark-field correction, excellent stability of the response over the entire panel of all imagers of 0.5% (1 SD) was obtained over an observation period up to 23 months. However, two imagers had to be replaced after several months. For one imager, an image segment stopped functioning, while the image quality of the other imager degraded significantly. We conclude that the tested a-Si EPIDs have a very stable response and are therefore well suited for dosimetry. We recommend, however, applying quality assurance tests dedicated to both imaging and dosimetry.

[1]  The stability of liquid-filled matrix ionization chamber electronic portal imaging devices for dosimetry purposes. , 2004, Medical physics.

[2]  D A Low,et al.  Commissioning and periodic quality assurance of a clinical electronic portal imaging device. , 1996, International journal of radiation oncology, biology, physics.

[3]  B. Heijmen,et al.  Daily dosimetric quality control of the MM50 Racetrack Microtron using an electronic portal imaging device , 1995 .

[4]  D. Jaffray,et al.  A ghost story: spatio-temporal response characteristics of an indirect-detection flat-panel imager. , 1999, Medical physics.

[5]  M van Herk,et al.  Three-dimensional dose reconstruction of breast cancer treatment using portal imaging. , 2003, Medical physics.

[6]  A J Poynter Image quality parameters for the production standard Eliav PORTpro portal imaging device. , 1999, The British journal of radiology.

[7]  J J Sonke,et al.  Dose-response and ghosting effects of an amorphous silicon electronic portal imaging device. , 2003, Medical physics.

[8]  Peter B Greer,et al.  Dosimetric properties of an amorphous silicon electronic portal imaging device for verification of dynamic intensity modulated radiation therapy. , 2003, Medical physics.

[9]  S Shalev,et al.  A quality control test for electronic portal imaging devices. , 1996, Medical physics.

[10]  A G Glendinning,et al.  Dosimetric properties of the Theraview fluoroscopic electronic portal imaging device. , 2000, The British journal of radiology.

[11]  R. Boellaard,et al.  The dose response relationship of a liquid-filled electronic portal imaging device. , 1996, Medical physics.

[12]  P. Munro,et al.  Clinical use of electronic portal imaging: report of AAPM Radiation Therapy Committee Task Group 58. , 2001, Medical physics.

[13]  Ron S Sloboda,et al.  Quality assurance measurements of a-Si EPID performance. , 2004, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

[14]  K. Lam,et al.  Relative dosimetry using active matrix flat-panel imager (AMFPI) technology. , 1999, Medical physics.